Paper · 23447136
Multifocal radiculoneuropathy during ipilimumab treatment of melanoma.
Manousakis G and 7 others. Muscle Nerve, 2013. Cited by 56 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Papers, record 23447136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23447136
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Immunologic Factors | Major topic |
| Melanoma | Major topic |
| Polyradiculoneuropathy | Major topic |
| Skin Neoplasms | Major topic |
| Adult | |
| Antigens, CD | |
| Antigens, Differentiation, Myelomonocytic | |
| Cranial Nerves | |
| Electromyography | |
| Humans | |
| Ipilimumab | |
| Magnetic Resonance Imaging | |
| Male | |
| Neural Conduction | |
| Receptors, Cell Surface | |
| Sural Nerve | |
| Time Factors | |
| CD163 Antigen |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,620,216 | Immune Checkpoint Inhibitor-Related Dysautonomia in Merkel Cell Carcinoma: A Case Report. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/40620216 | PubMed |
| 39,822,883 | Drug-Induced Cauda Equina Syndrome in an 8-Year-Old Boy With Acute Lymphoblastic Leukemia: An Uncommon Case Report. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/39822883 | PubMed |
| 39,225,744 | Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients. | J Neurol | 2024 | https://conductscience.org/library/papers/39225744 | PubMed |
| 35,317,159 | Asymmetric limb weakness in Guillain-Barré syndrome: Three case reports. | World J Clin Cases | 2022 | https://conductscience.org/library/papers/35317159 | PubMed |
| 34,055,372 | Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapy. | Neurooncol Pract | 2021 | https://conductscience.org/library/papers/34055372 | PubMed |
| 33,767,971 | Systemic adverse effects and toxicities associated with immunotherapy: A review. | World J Clin Oncol | 2021 | https://conductscience.org/library/papers/33767971 | PubMed |
| 33,047,629 | Atezolizumab-Induced Bell's Palsy in a Patient With Small Cell Lung Cancer. | J Investig Med High Impact Case Rep | 2020 | https://conductscience.org/library/papers/33047629 | PubMed |
| 32,158,597 | Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors. | Immune Netw | 2020 | https://conductscience.org/library/papers/32158597 | PubMed |
| 32,063,772 | Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma. | Proc (Bayl Univ Med Cent) | 2020 | https://conductscience.org/library/papers/32063772 | PubMed |
| 31,816,078 | Management of rheumatic complications of ICI therapy: a rheumatology viewpoint. | Rheumatology (Oxford) | 2019 | https://conductscience.org/library/papers/31816078 | PubMed |
1 to 10 of 27
See all 27 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CTLA4 | 1,493 | PubTator's text mining | https://conductscience.org/library/genes/1493 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23447136
GET https://conductscience.org/api/papers/v1/23447136/cited_by?page=2